Vaxcyte, Inc.PCVXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+67.4%
5Y CAGR+60.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+67.4%/yr
vs +54.0%/yr prior
5Y CAGR
+60.9%/yr
Recent acceleration
Acceleration
+13.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.8x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $794.31M | +66.6% |
| 2024 | $476.64M | +43.4% |
| 2023 | $332.34M | +96.1% |
| 2022 | $169.45M | +116.1% |
| 2021 | $78.41M | +6.6% |
| 2020 | $73.56M | +61.3% |
| 2019 | $45.61M | +51.3% |
| 2018 | $30.14M | +135.8% |
| 2017 | $12.79M | - |